Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
IGMS
|
Misbah Tahir
CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 6,084 Added 15.08% |
-
|
Mar 15
2022 |
IGMS
|
Chris H Takimoto
CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 14,477 Added 28.14% |
-
|
Mar 15
2022 |
TIL
|
R Kent Mc Gaughy Jr
Director |
SELL
Other acquisition or disposition
|
Indirect | 260,323 Reduced 3.07% |
-
|
Mar 15
2022 |
CPF
|
Paul K Yonamine
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 284 Reduced 20.16% |
$7,909
$27.85 p/Share
|
Mar 15
2022 |
CPF
|
Agnes Catherine Ngo
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 671 Reduced 17.66% |
$18,687
$27.85 p/Share
|
Mar 15
2022 |
CPF
|
David Morimoto
Senior EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 251 Reduced 13.69% |
$6,990
$27.85 p/Share
|
Mar 15
2022 |
CPF
|
Arnold D Martines
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 179 Reduced 13.98% |
$4,985
$27.85 p/Share
|
Mar 15
2022 |
SWBI
|
Susan Jean Cupero
Vice President, Sales |
SELL
Payment of exercise price or tax liability
|
Direct | 676 Reduced 1.94% |
$10,620
$15.71 p/Share
|
Mar 15
2022 |
CAC
|
Jennifer Lloyd Mirabile
EVP |
BUY
Grant, award, or other acquisition
|
Direct | 784 Added 10.96% |
-
|
Mar 15
2022 |
CAC
|
Timothy P Nightingale
EVP |
BUY
Grant, award, or other acquisition
|
Direct | 1,067 Added 1.81% |
-
|
Mar 15
2022 |
CAC
|
Renee Smyth
EVP |
BUY
Grant, award, or other acquisition
|
Direct | 821 Added 5.07% |
-
|
Mar 15
2022 |
CAC
|
Patricia A Rose
EVP |
BUY
Grant, award, or other acquisition
|
Direct | 900 Added 6.62% |
-
|
Mar 15
2022 |
CAC
|
Ryan A Smith
EVP |
BUY
Grant, award, or other acquisition
|
Direct | 876 Added 8.0% |
-
|
Mar 15
2022 |
CAC
|
William H Martel
EVP |
BUY
Grant, award, or other acquisition
|
Direct | 929 Added 13.14% |
-
|
Mar 15
2022 |
CDRE
|
Brad Williams
PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct | 4,903 Reduced 21.17% |
$114,975
$23.45 p/Share
|
Mar 15
2022 |
CDRE
|
Brad Williams
PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct | 12,458 Added 34.98% |
$292,140
$23.45 p/Share
|
Mar 15
2022 |
CDRE
|
Blaine Browers
CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 3,649 Reduced 15.03% |
$92,539
$25.36 p/Share
|
Mar 15
2022 |
CDRE
|
Blaine Browers
CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 9,271 Added 27.64% |
$235,113
$25.36 p/Share
|
Mar 15
2022 |
SNBR
|
Robert Joseph Poirier
VP, CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 65 Reduced 3.13% |
$4,008
$61.66 p/Share
|
Mar 15
2022 |
SNBR
|
Kevin Kennedy Brown
EVP and CMO |
SELL
Discretionary transaction
|
Indirect | 3 Reduced 0.45% |
$190
$63.47 p/Share
|
Mar 15
2022 |
SNBR
|
David R Callen
EVP & CFO |
SELL
Discretionary transaction
|
Indirect | 18 Reduced 0.61% |
$1,142
$63.47 p/Share
|
Mar 15
2022 |
SNBR
|
Samuel R Hellfeld
EVP Chief Legal & Risk Officer |
SELL
Discretionary transaction
|
Indirect | 21 Reduced 0.49% |
$1,333
$63.47 p/Share
|
Mar 15
2022 |
SNBR
|
Shelly Radue Ibach |
SELL
Discretionary transaction
|
Indirect | 19 Reduced 0.12% |
$1,206
$63.47 p/Share
|
Mar 15
2022 |
SNBR
|
Christopher D Krusmark
EVP & Chief H.R. Officer |
SELL
Discretionary transaction
|
Indirect | 3 Reduced 0.23% |
$190
$63.47 p/Share
|
Mar 15
2022 |
VERV
|
Burt A Adelman |
BUY
Open market or private purchase
|
Indirect | 4,000 Added 31.5% |
$85,520
$21.38 p/Share
|
Mar 15
2022 |
PDFS
|
Shuo Zhang
Director |
SELL
Open market or private sale
|
Direct | 11,017 Reduced 51.53% |
$280,934
$25.5 p/Share
|
Mar 15
2022 |
HBNC
|
Lynn Kerber
EVP & SCCO |
BUY
Grant, award, or other acquisition
|
Direct | 1,090 Added 7.11% |
-
|
Mar 15
2022 |
HBNC
|
Kathie A De Ruiter
Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 1,246 Added 14.06% |
-
|
Mar 15
2022 |
HBNC
|
Todd A. Etzler
Executive Vice President & GC |
BUY
Grant, award, or other acquisition
|
Direct | 959 Added 7.68% |
-
|
Mar 15
2022 |
HBNC
|
Mark E Secor
Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 1,682 Added 9.18% |
-
|
Mar 15
2022 |
HBNC
|
Craig M Dwight
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,193 Added 1.13% |
-
|
Mar 15
2022 |
HBNC
|
Dennis Kuhn
Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 574 Added 3.2% |
-
|
Mar 15
2022 |
AOSL
|
Bing Xue
EVP-WW Sales & Bus Development |
SELL
Payment of exercise price or tax liability
|
Direct | 7,507 Reduced 12.45% |
$365,216
$48.65 p/Share
|
Mar 15
2022 |
AOSL
|
Bing Xue
EVP-WW Sales & Bus Development |
BUY
Grant, award, or other acquisition
|
Direct | 33,750 Added 32.06% |
-
|
Mar 15
2022 |
AOSL
|
Yifan Liang
CFO and Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 11,280 Reduced 6.41% |
$548,772
$48.65 p/Share
|
Mar 15
2022 |
AOSL
|
Yifan Liang
CFO and Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 45,500 Added 19.44% |
-
|
Mar 15
2022 |
AOSL
|
Stephen Chunping Chang
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 8,116 Reduced 2.73% |
$394,843
$48.65 p/Share
|
Mar 15
2022 |
AOSL
|
Stephen Chunping Chang
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 46,250 Added 12.96% |
-
|
Mar 15
2022 |
AOSL
|
Wenjun Li
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,869 Reduced 9.65% |
$90,927
$48.65 p/Share
|
Mar 15
2022 |
AOSL
|
Wenjun Li
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 13,000 Added 36.61% |
-
|
Mar 15
2022 |
AOSL
|
Mike F Chang
Chairman of Board |
SELL
Payment of exercise price or tax liability
|
Direct | 54,116 Reduced 1.24% |
$2,632,743
$48.65 p/Share
|
Mar 15
2022 |
AOSL
|
Mike F Chang
Chairman of Board |
BUY
Grant, award, or other acquisition
|
Direct | 162,500 Added 3.57% |
-
|
Mar 15
2022 |
HCAT
|
Linda Llewelyn
Chief People Officer |
SELL
Open market or private sale
|
Direct | 2,039 Reduced 3.08% |
$42,982
$21.08 p/Share
|
Mar 15
2022 |
AHH
|
James A Carroll
Director |
BUY
Grant, award, or other acquisition
|
Direct | 243 Added 0.81% |
$3,606
$14.84 p/Share
|
Mar 15
2022 |
AHH
|
John W. Snow
Director |
BUY
Grant, award, or other acquisition
|
Direct | 843 Added 0.42% |
$12,510
$14.84 p/Share
|
Mar 15
2022 |
MYE
|
Ronald M Defeo |
BUY
Open market or private purchase
|
Direct | 10,000 Added 16.7% |
$184,900
$18.49 p/Share
|
Mar 15
2022 |
CANO
|
Mark Novell
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 28,783 Added 33.24% |
-
|
Mar 15
2022 |
CANO
|
Brian D Koppy
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 181,280 Added 18.77% |
-
|
Mar 15
2022 |
CANO
|
Richard Aguilar
Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 171,641 Added 16.17% |
-
|
Mar 15
2022 |
CANO
|
David J Armstrong |
BUY
Grant, award, or other acquisition
|
Direct | 125,474 Added 19.88% |
-
|
Mar 15
2022 |